Indication (Knowledge Graph Relation)

Assertions: 7,287

Description: A relationship in the knowledge graph

Knowledge Graph Assertions

Source	Relation	Target
SID11112790 Compound (Entity type)	Indication Knowledge Graph Relation (Entity type)	Echinococcus granulosus infection of lung Disease or Phenotype (Entity type)
Estramustine Compound (Entity type)	Indication Knowledge Graph Relation (Entity type)	Prostatic Neoplasms Disease or Phenotype (Entity type)
(R)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide Compound (Entity type)	Indication Knowledge Graph Relation (Entity type)	Pulmonary Cystic Fibrosis Disease or Phenotype (Entity type)
glycine Compound (Entity type)	Indication Knowledge Graph Relation (Entity type)	Irritation of nose Disease or Phenotype (Entity type)
Fluvastatin sodium Compound (Entity type)	Indication Knowledge Graph Relation (Entity type)	Familial hypercholesterolemia - heterozygous Disease or Phenotype (Entity type)
Ethinamate Compound (Entity type)	Indication Knowledge Graph Relation (Entity type)	Sleeplessness Disease or Phenotype (Entity type)
Flutemetamol f18 Compound (Entity type)	Indication Knowledge Graph Relation (Entity type)	Positron-Emission Tomography Disease or Phenotype (Entity type)
Ethambutol Compound (Entity type)	Indication Knowledge Graph Relation (Entity type)	Tuberculosis, Pulmonary Disease or Phenotype (Entity type)
Lutein Compound (Entity type)	Indication Knowledge Graph Relation (Entity type)	Dry Eye Syndromes Disease or Phenotype (Entity type)
Pepcid Compound (Entity type)	Indication Knowledge Graph Relation (Entity type)	Gastric ulcer Disease or Phenotype (Entity type)

SID11112790
Compound (Entity type)
Indication
Knowledge Graph Relation (Entity type)
Echinococcus granulosus infection of lung
Disease or Phenotype (Entity type)

Estramustine
Compound (Entity type)
Indication
Knowledge Graph Relation (Entity type)
Prostatic Neoplasms
Disease or Phenotype (Entity type)

(R)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide
Compound (Entity type)
Indication
Knowledge Graph Relation (Entity type)
Pulmonary Cystic Fibrosis
Disease or Phenotype (Entity type)

glycine
Compound (Entity type)
Indication
Knowledge Graph Relation (Entity type)
Irritation of nose
Disease or Phenotype (Entity type)

Fluvastatin sodium
Compound (Entity type)
Indication
Knowledge Graph Relation (Entity type)
Familial hypercholesterolemia - heterozygous
Disease or Phenotype (Entity type)

Ethinamate
Compound (Entity type)
Indication
Knowledge Graph Relation (Entity type)
Sleeplessness
Disease or Phenotype (Entity type)

Flutemetamol f18
Compound (Entity type)
Indication
Knowledge Graph Relation (Entity type)
Positron-Emission Tomography
Disease or Phenotype (Entity type)

Ethambutol
Compound (Entity type)
Indication
Knowledge Graph Relation (Entity type)
Tuberculosis, Pulmonary
Disease or Phenotype (Entity type)

Lutein
Compound (Entity type)
Indication
Knowledge Graph Relation (Entity type)
Dry Eye Syndromes
Disease or Phenotype (Entity type)

Pepcid
Compound (Entity type)
Indication
Knowledge Graph Relation (Entity type)
Gastric ulcer
Disease or Phenotype (Entity type)

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.